Le Lézard
Classified in: Health, Business
Subjects: FNC, VEN

Koya Medical Raises New Capital with OrbiMed to Support Growth


OAKLAND, Calif. and NEW YORK, Nov. 15, 2023 /PRNewswire/ -- OrbiMed, a leading healthcare investment firm and Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through novel, people-centric solutions, today announced the closing of a financing for up to $30 million. The capital will support the company's strategic expansion and continued growth.

"We are excited to partner with Koya on its journey to deliver innovative offerings that can help millions of patients living with these chronic conditions," said Matthew Rizzo, General Partner, OrbiMed. "Lymphedema treatments are an underserved area for many patients, and we are just beginning to understand the full impact these diseases have on patients' daily lives. We are pleased to have OrbiMed join us along with our existing investors on this important mission," said Josh Baltzell, Board Chairman, Koya Medical.

With the close of this financing, Koya is well positioned to continue the growth of its Dayspring treatment for lymphedema. "Lymphedema and chronic venous diseases have tremendous unmet needs where millions of patients suffer due to the progressive nature of these conditions and their debilitating impacts. With OrbiMed joining our journey, we will be able to make a stronger impact in improving patient lives," said Andy Doraiswamy, CEO. "This partnership and funding will enhance our abilities to better serve our patients."

About Lymphedema

An estimated 20 million Americans live with lymphedema, a progressive, incurable condition where a buildup of protein rich fluid causes painful swelling in the arm, leg, and/or other regions of the body. For most, lymphedema requires lifelong maintenance and various levels of therapy to control swelling and pain. Lymphedema can result from a variety of factors, including cancer, chronic venous disease, infection, and surgery. 

About Koya Medical

Koya Medical, a privately held company founded in 2018, is a transformative healthcare company developing breakthrough treatments for venous diseases and lymphedema and personalized care that is unavailable with traditional treatments. For company or product inquiry, contact [email protected].
Follow us on LinkedIn at www.linkedin.com/company/koyamedical/.

SOURCE Koya Medical


These press releases may also interest you

18 mai 2024
Agway of Cape Cod and Seaside Cannabis Company announce their partnership for the inaugural Clone Fest, set to take place on Sunday, May 19th. The event will be held at both locations, conveniently situated next to each other at 14 and 20 Lots Hollow...

18 mai 2024
Annick Timmer embodies the spirit of a vibrant entrepreneur and serves as the co-founder of The EBH Group, a distinguished firm specializing in ultra-luxury real estate and interior design. Within The EBH Group, Annick assumes a...

18 mai 2024
The Prime Minister, Justin Trudeau, today issued the following statement on Tamil Genocide Remembrance Day: "Fifteen years ago, the quarter-century-long armed conflict in Sri Lanka came to an end. Tens of thousands of Tamils tragically lost their...

18 mai 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of UnitedHealth Group Inc. between March 14, 2022 and February 27, 2024, both dates inclusive (the "Class...

18 mai 2024
SPECIALIST business utilities retailer Love Energy Savings is now a BT Authorised Partner for business connectivity products, including broadband. The move will double the UK addressable market of Love Energy Savings to all 5.5 million small and...

18 mai 2024
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 18, 2024. OKX...



News published on and distributed by: